Royal Bank of Canada
AHPI

Royal Bank of Canada’s Allied Healthcare Products AHPI Stock Holding History

Royal Bank of Canada’s Portfolio AHPI Stock Details AHPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed – – 7813
2022
Q4 		$0 Hold
100
– – ﹤0.01% 8069
2022
Q3 		$0 Hold
100
– – ﹤0.01% 8155
2022
Q2 		$0 Buy
+100
New +$227 ﹤0.01% 8052
2021
Q2 		– Sell
-2,000
Closed -$9K – 7813
2021
Q1 		$9K Buy
+2,000
New +$11.4K ﹤0.01% 6873
2020
Q4 		– Sell
-2,000
Closed -$11K – 7395
2020
Q3 		$11K Buy
2,000
+1,700
+567% +$14.4K ﹤0.01% 5905
2020
Q2 		$4K Sell
300
-1,000
-77% -$11.9K ﹤0.01% 6135
2020
Q1 		$23K Buy
+1,300
New +$10.1K ﹤0.01% 5489

Royal Bank of Canada's AHPI Position: Q1 2023 in Review

Royal Bank of Canada sold out of Allied Healthcare Products (AHPI) in Q1 2023, closing a stake of 100 shares.

Royal Bank of Canada first reported a position in AHPI in Q1 2020 and held it in 7 quarters. The position peaked at $23K in Q1 2020. 1 fund tracked by Wall St. Rank holds AHPI as of Q1 2023.

  • Royal Bank of Canada reported no remaining Allied Healthcare Products position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 100 Allied Healthcare Products shares in Q1 2023.
  • Royal Bank of Canada first reported a position in Allied Healthcare Products in Q1 2020 and held it in 7 quarters.
  • Royal Bank of Canada's Allied Healthcare Products position peaked at $23K in Q1 2020.
  • 1 fund tracked by Wall St. Rank held Allied Healthcare Products as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.